Cargando…
Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction
The prognosis of patients with myocardial infarction (MI) and resultant chronic heart failure remains extremely poor despite advances in optimal medical therapy and interventional procedures. Animal experiments and clinical trials using adult stem cell therapy following MI have shown a global improv...
Autores principales: | Wen, Zhuzhi, Zheng, Shaoxin, Zhou, Changqing, Wang, Jingfeng, Wang, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822616/ https://www.ncbi.nlm.nih.gov/pubmed/21199333 http://dx.doi.org/10.1111/j.1582-4934.2010.01255.x |
Ejemplares similares
-
Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators
por: Wen, Zhuzhi, et al.
Publicado: (2012) -
Local activation of cardiac stem cells for post-myocardial infarction cardiac repair
por: Wen, Zhuzhi, et al.
Publicado: (2012) -
A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction
por: Miao, Chi, et al.
Publicado: (2017) -
Comparison of renal impairment post-myocardial infarction with reduced and preserved left ventricular function in rats with normal renal function
por: Wen, Zhuzhi, et al.
Publicado: (2020) -
FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction
por: Deng, Jingyu, et al.
Publicado: (2020)